We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
AUNOC | Aurumin Limited | 0.005 | 0.003 | 150.00% | 8,369,788 | 6 |
MRD | Mount Ridley Mines Ltd | 0.002 | 0.001 | 100.00% | 598,894 | 3 |
UNTOA | Unith Ltd | 0.005 | 0.002 | 66.67% | 450,000 | 5 |
FRE | Firebrick Pharma Ltd | 0.081 | 0.03 | 58.82% | 9,073,276 | 459 |
NWMO | Norwest Minerals Limited | 0.015 | 0.005 | 50.00% | 625,000 | 6 |
MTMO | MTM Critical Metals Ltd | 0.003 | 0.001 | 50.00% | 531,250 | 3 |
TG1O | TechGen Metals Ltd | 0.003 | 0.001 | 50.00% | 120,458 | 1 |
BUR | Burley Minerals Ltd | 0.065 | 0.018 | 38.30% | 1,309,622 | 45 |
SFG | Seafarms Group Limited | 0.004 | 0.001 | 33.33% | 417,160 | 3 |
IEC | Intra Energy Corporation Ltd | 0.002 | 0.0005 | 33.33% | 675,000 | 4 |
MEG | Megado Minerals Ltd | 0.013 | 0.003 | 30.00% | 318,437 | 7 |
HONG KONG, April 17, 2024 /PRNewswire/ -- ICZOOM Group Inc. (Nasdaq: IZM) (the "Company" or "ICZOOM"), announced today that it voluntarily requested a withdrawal of a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (File No.333-275708, the "Registration Statement") and accordingly cancelled the proposed public offering pursuant to the Registration Statement .
WASHINGTON, April 17, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today announced that its Board of Directors (the "Board") has adopted a limited duration stockholder rights plan (the "Rights Plan") to protect stockholder interests and maximize value for all stockholders. The Rights Plan is effective immediately.
LuxUrban Hotels Inc. (or the “Company”) (Nasdaq: LUXH, LUXHP), a hospitality company which leases entire existing hotels on a long-term basis and rents rooms in its hotels to business and vacation travelers, including through its partnership with Wyndham Hotels & Resorts (“Wyndham”), today announced financial results for full year (“FY 2023”) ended December 31, 2023, including EBITDA and adjusted EBITDA, which are non-GAAP measures and are accompanied by reconciliation tables in this release. The Company also announced that it filed its Form 10-K with the Securities and Exchange Commission on April 15, 2024.
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that an independent Data Monitoring Committee (DMC) has recommended continuing the pivotal Phase 3 RAISE trial evaluating intravenous (IV) ganaxolone for the treatment of refractory status epilepticus (RSE) following an interim analysis.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 61,240.80 | -2,603.16 | -4.08% | 1.21T | 6,869,468,334 |
ETH | Ethereum | 3,017.67 | -66.81 | -2.17% | 363.43B | 2,917,795,828 |
USDT | Tether USD | 0.99995 | -0.00005 | 0.00% | 97.84B | 466,941,796 |
BNB | Binance Coin | 531.48 | -6.66 | -1.24% | 84.24B | 434,953,277 |
SOL | Solana | 134.71 | -1.66 | -1.22% | 59.68B | 2,067,491,803 |
STETH | stETH | 3,012.69 | -51.58 | -1.68% | 29.61B | 15,370,439 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 1,172,808,437 |
XRP | Ripple | 0.4987 | 0.002 | 0.40% | 27.24B | 419,963,275 |
DOGE | Dogecoin | 0.14908 | -0.00697 | -4.47% | 21.48B | 626,775,442 |
TONCOIN | Wrapped TON Coin | 6.26 | -0.096953 | -1.53% | 21.36B | 229,816,232 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions